Bioanalytics
Matthew Lauber, PhD
Sr Director – Cell and Gene Therapy
Waters Corporation
Milford, Massachusetts
Description: In this presentation, we will describe insights on LC-based methods that have made it possible to characterize and quantify oligonucleotide molecules exhibiting significant differences in size, charge, and hydrophobicity. Moreover, we will introduce a new platform-ready sample preparation protocol that has been developed explicitly for high sensitivity LC-tandem MS quantitation and for use with a diverse range of analytes, including heavily modified, lipid conjugated drug products.